|
|
???tair.name??? >
???browser.page.title.author???
|
"shiah hs"???jsp.browse.items-by-author.description???
Showing items 1-25 of 42 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2021-03-01 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
|
Tsai, HJ;Shiah, HS;Chang, JY;Su, WC;Chiang, NJ;Chen, LT |
| 國家衛生研究院 |
2020-11-27 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors
|
Shiah, HS;Chiang, NJ;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Wang, CC;Chang, JY;Chen, LT |
| 國家衛生研究院 |
2020-11-03 |
A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma
|
Changou, CA;Shiah, HS;Chen, LT;Liu, S;Luh, F;Liu, SH;Cheng, YC;Yen, Y |
| 國家衛生研究院 |
2020-04 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono, J;Lin, CC;Chen, LT;Corral, J;Michalarea, V;Rihawi, K;Ong, M;Lee, JH;Hsu, CH;Yang, JC;Shiah, HS;Yen, CJ;Anthoney, A;Jove, M;Buschke, S;Fuertig, R;Schmid, U;Goeldner, RG;Strelkowa, N;Huang, DC;Bogenrieder, T;Twelves, C;Cheng, AL |
| 國家衛生研究院 |
2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients
|
Dai, MS;Chao, TC;Chiu, CF;Lu, YS;Shiah, HS;Wu, YY;Cheng, WH;Chan, WK;Hung, T;Hung, N;Cutler, D;Kwan, R;Kramer, D;Chao, TY |
| 國家衛生研究院 |
2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy
|
Chiang, NJ;Shiah, HS;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Chen, LT |
| 國家衛生研究院 |
2016-02 |
Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors
|
Tsai, HJ;Chiang, NJ;Shiah, HS;Chang, KY;Su, WC;Chang, JY;Chen, LT |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-03 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, TC;Shiah, HS;Yang, CH;Yeh, KH;Cheng, AL;Shen, BN;Wang, YW;Yeh, CG;Chiang, NJ;Chang, JY;Chen, LT |
| 臺北醫學大學 |
2014 |
Jejunal Cancer with WRN Mutation Identified from Next-Generation Sequencing: A Case Study and Minireview
|
Chang, C;Shiah, HS;Hsu, NY;Huang, HY;Chu, JS;Yen, Y |
| 國家衛生研究院 |
2013-05 |
Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma
|
Lin, CCJ;Hsu, CH;Cheng, JC;Yen, CC;Shiah, HS;Huang, TC;Chen, WW;Wang, HP;Yeh, KH;Lee, JM;Cheng, AL |
| 國家衛生研究院 |
2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
|
Shiah, HS;Chen, CY;Dai, CY;Hsiao, CF;Lin, YJ;Su, WC;Chang, JY;Whang-Peng, J;Lin, PW;Huang, JD;Chen, LT |
| 國家衛生研究院 |
2012-02 |
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy
|
Chen, LT;Shiah, HS;Lin, PC;Lee, JC;Su, WC;Wang, YW;Yeh, G;Chang, JY |
| 國家衛生研究院 |
2011-12-15 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors
|
Kuo, CC;Liu, TW;Chen, LT;Shiah, HS;Wu, CM;Cheng, YT;Pan, WY;Liu, JF;Chen, KL;Yang, YN;Chen, SN;Chang, JY |
| 國家衛生研究院 |
2011-10 |
Novel feedback inhibition of surface antigen synthesis by Mammalian Target of Rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy
|
Teng, CF;Wu, HC;Tsai, HW;Shiah, HS;Huang, W;Su, IJ |
| 國家衛生研究院 |
2011-04 |
Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas
|
Kuo, CC;Chang, JY;Cheng, YT;Wan, HJ;Lee, WS;Chen, HH;Chang, CY;Pan, WY;Chen, LT;Shiah, HS |
| 高雄醫學大學 |
2011 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.
|
陳立宗; Kuo CC;Liu TW;Chen LT;Shiah HS;Wu CM;Cheng YT;Pan WY;Liu JF;Chen KL;Yang YN;Chen SN;Chang JY. |
| 國家衛生研究院 |
2009-12 |
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent
|
Chen, LT;Shiah, HS;Chao, Y;Chang, JY;Cheng, LT;Whang-Peng, J |
| 國家衛生研究院 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, HJ;Huang, CL;Wang, HP;Shiah, HS;Chang, MC;Jan, CM;Chen, JS;Tien, YW;Hwang, TL;Lin, JT;Cheng, AL;Whang-Peng, J;Chen, LT |
| 國立臺灣大學 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. Cancer Chemother Pharmacol.
|
Chang, HJ; Huang, CL; Wang, HP; Shiah, HS; Chang, MC; Jan, CM; Chen, JS; Tien, YW; Hwang, TL; Lin, JT; Cheng, AL; Whang-Peng, J; Chen, LT. |
| 國家衛生研究院 |
2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Chen, L;Shiah, HS;Chen, CY;Lin, YJ;Lin, PW;Su, WC;Chang, JY |
| 國家衛生研究院 |
2007-11-15 |
Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells
|
Kuo, CC; Liu, JF; Shiah, HS; Ma, LC; Chang, JY |
| 國家衛生研究院 |
2007-03-01 |
Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036
|
Shiah, HS; Lee, WS; Juang, SH; Hong, PC; Lung, CC; Chang, CJ; Chou, KM; Chang, FY |
| 國家衛生研究院 |
2007-01 |
D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation
|
Juang, SH;Lung, CC;Hsu, PC;Hsu, KS;Li, YC;Hong, PC;Shiah, HS;Kuo, CC;Huang, CW;Wang, YC;Huang, L;Chen, TS;Chen, SF;Fu, KC;Hsu, CL;Lin, MJ;Chang, CJ;Ashendel, CL;Chan, TCK;Chou, KM;Chang, JY |
| 國家衛生研究院 |
2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW |
Showing items 1-25 of 42 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
